Ansel GM - Search Results

1

Protected carotid stenting in high-risk patients with severe carotid artery stenosis.

Safian RD, Bresnahan JF, Jaff MR, Foster M, Bacharach JM, Maini B, Turco M, Myla S, Eles G, Ansel GM; CREATE Pivotal Trial Investigators. Safian RD, et al. Among authors: ansel gm. J Am Coll Cardiol. 2006 Jun 20;47(12):2384-9. doi: 10.1016/j.jacc.2005.12.076. J Am Coll Cardiol. 2006. PMID: 16781363 Free article. Clinical Trial.

2

Carotid stenting with a new system for distal embolic protection and stenting in high-risk patients: the carotid revascularization with ev3 arterial technology evolution (CREATE) feasibility trial.

Safian RD, Bacharach JM, Ansel GM, Criado FJ. Safian RD, et al. Among authors: ansel gm. Catheter Cardiovasc Interv. 2004 Sep;63(1):1-6. doi: 10.1002/ccd.20155. Catheter Cardiovasc Interv. 2004. PMID: 15343559 Clinical Trial.

3

Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease.

Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G; VIVA Physicians, Inc. Rocha-Singh KJ, et al. Catheter Cardiovasc Interv. 2007 May 1;69(6):910-9. doi: 10.1002/ccd.21104. Catheter Cardiovasc Interv. 2007. PMID: 17377972

4

Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices.

Jaff M, Dake M, Pompa J, Ansel G, Yoder T. Jaff M, et al. Catheter Cardiovasc Interv. 2007 Sep;70(3):460-2. doi: 10.1002/ccd.21240. Catheter Cardiovasc Interv. 2007. PMID: 17559108 Review.

5

Carotid artery revascularization in high-surgical-risk patients using the Carotid WALLSTENT and FilterWire EX/EZ: 1-year outcomes in the BEACH Pivotal Group.

Iyer SS, White CJ, Hopkins LN, Katzen BT, Safian R, Wholey MH, Gray WA, Ciocca R, Bachinsky WB, Ansel G, Joye JD, Russell ME; BEACH Investigators. Iyer SS, et al. J Am Coll Cardiol. 2008 Jan 29;51(4):427-34. doi: 10.1016/j.jacc.2007.09.045. J Am Coll Cardiol. 2008. PMID: 18222352 Free article. Clinical Trial.

6

Long-term results of carotid stenting versus endarterectomy in high-risk patients.

Gurm HS, Yadav JS, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Ansel G, Strickman NE, Wang H, Cohen SA, Massaro JM, Cutlip DE; SAPPHIRE Investigators. Gurm HS, et al. N Engl J Med. 2008 Apr 10;358(15):1572-9. doi: 10.1056/NEJMoa0708028. N Engl J Med. 2008. PMID: 18403765 Free article. Clinical Trial.

7

Carotid stenting with embolic protection: evolutionary advances.

Ansel GM, Jaff MR. Ansel GM, et al. Expert Rev Med Devices. 2008 Jul;5(4):427-36. doi: 10.1586/17434440.5.4.427. Expert Rev Med Devices. 2008. PMID: 18573043 Review.

8

The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices.

Ansel GM, Jaff MR. Ansel GM, et al. Catheter Cardiovasc Interv. 2008 Dec 1;72(7):998-1002. doi: 10.1002/ccd.21776. Catheter Cardiovasc Interv. 2008. PMID: 19021289

9

Carotid artery stenting in high surgical risk patients using the FiberNet embolic protection system: the EPIC trial results.

Myla S, Bacharach JM, Ansel GM, Dippel EJ, McCormick DJ, Popma JJ. Myla S, et al. Among authors: ansel gm. Catheter Cardiovasc Interv. 2010 May 1;75(6):817-22. doi: 10.1002/ccd.22386. Catheter Cardiovasc Interv. 2010. PMID: 20201102

10

Safety and effectiveness of the INVATEC MO.MA proximal cerebral protection device during carotid artery stenting: results from the ARMOUR pivotal trial.

Ansel GM, Hopkins LN, Jaff MR, Rubino P, Bacharach JM, Scheinert D, Myla S, Das T, Cremonesi A; Investigators for the ARMOUR Pivotal Trial. Ansel GM, et al. Catheter Cardiovasc Interv. 2010 Jul 1;76(1):1-8. doi: 10.1002/ccd.22439. Catheter Cardiovasc Interv. 2010. PMID: 20222019 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page